EyePoint Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2013 to Q2 2024.
  • EyePoint Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 53.2M shares, a 41.6% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 38.9M shares, a 4.25% increase from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 37.3M shares, a 29.8% increase from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 28.8M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 53.2M +15.6M +41.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 52.9K* +15.4K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 38.9M +1.59M +4.25% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 38.3M +1M +2.69% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 37.6M +254K +0.68% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 37.5K* -37.2M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 37.3M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 37.3M +8.57M +29.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 37.3M +8.58M +29.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 37.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 28.8M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 28.7M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q2 2016 31.6M +2.21M +7.52% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-13
Q1 2016 33.5M +4.13M +14% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-06
Q4 2015 29.4M +69.9K +0.24% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-09
Q3 2015 29.4M +93K +0.32% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-06
Q2 2015 29.4M +1.97M +7.17% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-13
Q1 2015 29.4M +1.74M +6.29% Jan 1, 2015 Mar 31, 2015 10-K 2016-09-13
Q4 2014 29.4M +2.41M +8.96% Oct 1, 2014 Dec 31, 2014 10-K 2016-09-13
Q3 2014 29.3M +3.41M +13.1% Jul 1, 2014 Sep 30, 2014 10-K 2016-09-13
Q2 2014 27.4M Apr 1, 2014 Jun 30, 2014 10-K 2016-09-13
Q1 2014 27.7M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 27M Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-06
Q3 2013 25.9M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.